跳至主要内容
临床试验/NCT00000349
NCT00000349Unknown1 期

Infusion Laboratory: Protocol 5 (Flupenthixol)

National Institute on Drug Abuse (NIDA)2 个研究点 分布在 1 个国家开始时间: 1999年9月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
试验地点
2
主要终点
Clinical physiological response to cocaine challen

研究概览

简要总结

The purpose of this study is to evaluate clinical safety issues pertaining to flupenthixol, to cocaine, and to their interaction, and to determine how pretreatment with flupenthixol modifies the subjective as well as physiological effects of cocaine. Taken together, these relatively D-1 selective agents can help determine the extent to which DA-1 binding affects the reinforcing effects of stimulants.

研究设计

研究类型
Interventional
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • M/F, ages 21-
  • Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent.

排除标准

  • Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.

结局指标

主要结局

Clinical physiological response to cocaine challen

Degree of drug craving

History, incidence and amount of drug use

Type and severity of stimulant withdrawal symptoms

Characterization of study population

Frequency and intensity of drug use and sexual beh

Evidence of change in neurophysiology and brain ac

Evidence of change in subjective responses to coca

Degree to which study medication influences change

Population incidence of symptoms of depression, po

次要结局

未报告次要终点

研究者

申办方类型
Nih

研究点 (2)

Loading locations...

相似试验